Cyclin D1 expression in invasive breast cancer: Correlations and prognostic value

American Journal of Pathology

Volumn 150, Issue 2, 1997, Pages 705-711

  Van Diest, Paul J ^a   Michalides, Rob J A M ^b   Jannink, Ilse ^a   Van der Valk, Paul ^a   Peterse, Hans L ^b   De Jong, Johannes S ^a   Meijer, Chris J L M ^a   Baak, Jan P A ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b NETHERLANDS CANCER INSTITUTE   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN D1;

ARTICLE; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER CLASSIFICATION; CANCER INVASION; FEMALE; FLOW CYTOMETRY; FOLLOW UP; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MASTECTOMY; MITOSIS RATE; MORPHOMETRICS; PRIORITY JOURNAL; PROGNOSIS; STATISTICAL ANALYSIS;

BREAST NEOPLASMS; CYCLIN D1; CYCLINS; FEMALE; FLOW CYTOMETRY; HUMANS; IMMUNOHISTOCHEMISTRY; MULTIVARIATE ANALYSIS; NEOPLASM INVASIVENESS; ONCOGENE PROTEINS; PROGNOSIS; SURVIVAL ANALYSIS;

EID: 0031031998     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Aaltomaa S, Lipponen P, Eskelinen M, Kosma VM, Marin S, Alhava E, Syrjanen K: Prognostic factors in axillary lymph node-negative (pN-) breast carcinomas. Eur J Cancer 1991, 27:1555-1559
2. Baak JPA, van Dop H, Kurver PHJ, Hermans J: The value of morphometry to classic prognosticators in breast cancer. Cancer 1985, 56:374-382
3. Clayton F: Pathologic correlates of survival in 378 lymph node-negative infiltrating ductal breast carcinomas: mitotic count is the best single predictor. Cancer 1991, 68:1309-1317
4. van Diest PJ, Baak JPA: The morphometric multivariate prognostic index (MPI) is the strongest prognosticator in premenopausal lymph node negative and lymph node positive breast cancer patients. Hum Pathol 1991, 22:326-330
5. van der Linden JC, Baak JPA, Lindeman J, Hermans J, Meijer CJLM: Prospective evaluation of prognostic value of morphometry in patients with primary breast cancer. J Clin Pathol 1987, 40:302-306
6. Uyterlinde AM, Schipper NW, Baak JPA, Peterse H, Matze P: Limited prognostic value of cellular DNA content to classical and morphometrical parameters in invasive ductal breast cancer. Am J Clin Pathol 1988, 89:301-307
7. Joensuu H, Toikkanen S, Klemi PJ: DNA index and S-phase fraction and their combination as prognostic factors in operable ductal breast carcinoma. Cancer 1990, 66:331-340
8. Sigurdsson H, Baldetorp B, Borg A, Dalberg M, Ferno M, Killander D, Olsson H: Indicators of prognosis in node-negative breast cancer. N Engl J Med 1990, 322:1045-1053
9. Bouzubar N, Walker KJ, Griffiths K, Ellis IO, Elston CW, Robertson JFR, Blarney RW, Nicholson RI: Ki67 immunostaining in primary breast cancer: pathological and clinical associations. Br J Cancer 1989, 59:943-947
10. Sahin AA, Ro J, Ro JY, Blick MB, El-Naggar AK, Ordonez NG, Fritsche HA, Smith TL, Hortobagyi GN, Ayala AG: Ki-67 immunostaining in node-negative stage I/II breast carcinoma: significant correlation with prognosis. Cancer 1991, 68:549-557
11. Kamel OW, Franklin WA, Ringus JC, Meyer JS: Thymidine labeling index and Ki-67 growth fraction in lesions of the breast. Am J Pathol 1989, 134:107-113
12. Meyer JS, Friedman E, McCrate MM, Bauer WC: Prediction of early course of breast carcinoma by thymidine labeling. Cancer 1983, 51:1879-1886
13. Karp JE, Broder S: Molecular foundations of cancer: new targets for intervention. Nature Med 1995, 1:309-320
14. Lukas J, Pagano M, Staskova Z, Draetta G, Bartek J: Cyclin D1 protein oscillates and is essential for cell cycle progression in human tumour cell lines. Oncogene 1994, 9:707-718
15. Michalides R, Veelen N van, Hart A, Loftus B, Wientjens E, Balm A: Overexpression of cyclin D1 correlates with recurrence in a group of forty-seven operable squamous cell carcinomas of the head and neck. Cancer Res 1995, 55:975-978
16. Michalides R, Hageman PH, van Tinteren H, Houben L, Wientjens E, Klompmaker R, Peterse J: A clinico-pathological study on overexpression of cyclin D1 and of p53 in a series of 248 patients with operable breast cancer. Br J Cancer 1996, 73:728-734
17. Musgrove EA, Lee CSL, Buckley MF, Sutherland RL: Cyclin D1 induction in breast cancer cells arrested in G1 to complete the cell cycle. Proc Natl Acad Sci USA 1994, 91:8022-8026
18. Schuuring E, Verhoeven E, Mooi WJ, Michalides RJAM: Identification and cloning of two overexpressed genes, U21B31/PRAD1 and EMS1, within the amplified chromosome 11q13 region in human carcinomas. Oncogene 1992, 7:355-361
19. Schuuring E, Verhoeven E, van Tinteren H, Peterse JL, Nunnink B, Thunnissen FBJM, Devilee P, Cornelisse CJ, van de Vijver MJ, Mooi WJ, Michalides RJAM: Amplification of genes within the chromosome 11q13 region is indicative of poor prognosis in patients with operable breast cancer. Cancer Res 1992, 52:5229-5234
20. Lammie GA, Fantl V, Smith R, Schuuring E, Brooks E, Michalides RJAM: D112287, a putative oncogene on chromosome 11q13 is amplified and expressed in squamous cell and mammary carcinomas and linked to bcl-1. Oncogene 1991, 6:439-444
21. Rosenberg CL, Kim HG, Shows TB, Kronenberg HM, Arnold A: Rearrangement and overexpression of D11S287E, a candidate oncogene on chromosome 11q13 in benign parathyroid tumours. Oncogene 1991, 6:449-453
22. Motokura T, Bloom T, Kim HG, Jüppner H, Ruderman JV, Kronenberg HM, Arnold A: A novel cyclin encoded by a bcl1-linked candidate oncogene. Nature 1991, 350:512-515
23. Bartkova J, Lukas J, Müller H, Lützhoft D, Strauss M, Bartek J: Cyclin D1 protein expression and function in human breast cancer. Int J Cancer 1994, 57:353-361
24. Gillet C, Fantl V, Smith R, Fisher G, Bartek J, Dickson C, Barnes D, Peters G: Amplification and overexpression of cyclin D1 in breast cancer detected by immunohistochemical staining. Cancer Res 1994, 54:1812-1817
25. Zhang SY, Caamano J, Cooper F, Guo X, Klein-Szanto AJP: Immunohistochemistry of cyclin D1 in human breast cancer. Am J Clin Pathol 1994, 102:695-698
26. Zukerberg LR, Yang WI, Arnold A, Harris NL: Cyclin D1 expression in non-Hodgkin's lymphomas: detection by immunohistochemistry. Am J Clin Pathol 1995, 103:756-760
27. Bodey B, Williams RT, Carbonaro-Hall DA, Horvath A, Tolo VT, Luck JV, Taylor CR, Hall FL: Immunohistochemical detection of cyclin A and cyclin D in formalin-fixed, paraffin embedded tissues: novel, pertinent markers of cell proliferation. Mod Pathol 1994, 7:846-852
28. Jannink I, Bennen JN, J Blauw, van Diest PJ, Baak JPA: Comparative prognostic value of systematic random and at convenience sampling in breast cancer. Breast Cancer Res Treat 1995, 36:55-60
29. Page DL, Anderson TJ (Eds): Diagnostic Histopathology of the breast. Edinburgh, Churchill Livingstone, 1987
30. Hedley DW, Friedlander ML, Taylor IW, Rugg CA, Musgrove EA: Method for analysis of cellular DNA content of paraffin-embedded pathological material using flow cytometry. J Histochem Cytochem 1983, 31:1333-1335
31. Fleege JC, van Diest PJ, Baak JPA: Computer assisted efficiency-testing of different sampling methods for selective nuclear graphic tablet morphometry. Lab Invest 1990, 63:270-275
32. Baak JPA, Ladekarl M, Sørensen FB: Reproducibility of mean nuclear volume and correlation with mean nuclear area in breast cancer: an investigation of various sampling schemes. Hum Pathol 1994, 25:80-85
33. Ellis IO, Galea M, Broughton N, Locker A, Blarney RW, Elston CW: Pathological prognostic factors in breast cancer: II. Histological type: relationship with survival in a large study with long term follow up. Histopathology 1992, 20:479-489
34. Quelle DE, Ashmun RA, Shurtleff SA, Kato JY, Bar-Sagi D, Roussel MF, Sherr CJ: Overexpression of mouse D-type cyclins accelerates G1 phase in rodent fibroblasts. Genes Dev 1993, 7:1559-1571
35. Jiang W, Kahn SM, Zhou P, Zhang YJ, Cacace AM, Infante AS, Doi S, Santella RM, Weinstein IB: Overexpression of cyclin D1 in rat fibroblasts causes abnormalities in growth control, cell cycle progression, and gene expression. Oncogene 1993, 8:3447-3457
36. Bates S, Parry S, Bonetta L, Vousden K, Dickson C, Peters G: Absence of cyclin D/cdk complexes in cells lacking functional retinoblastoma protein. Oncogene 1994, 9:1633-1640